Prognostic factors in potentially resectable stage III non-small cell lung cancer receiving neoadjuvant treatment—a narrative review

Lung cancer is the leading cause of cancer-related death in worldwide. The most important treatment for patients with stage I and II non-small cell lung cancer (NSCLC) is surgery. Resected stage II and III NSCLC patients should be offered adjuvant chemotherapy and in patients with resected stage IB...

Descripción completa

Detalles Bibliográficos
Autores principales: Calvo, Virginia, Aliaga, Carlos, Carracedo, Carlos, Provencio, Mariano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Articles on Multimodal Management of Locally Advanced N2 Non-small Cell Lung Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867763/
https://www.ncbi.nlm.nih.gov/pubmed/33569338
http://dx.doi.org/10.21037/tlcr-20-515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867763/
https://www.ncbi.nlm.nih.gov/pubmed/33569338
http://dx.doi.org/10.21037/tlcr-20-515

Ejemplares similares